SCHEMBL493606

SCHEMBL493606

CN(CCl)S(=O)(=O)c1c(Cl)cc(Cl)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.38
ALDH1A1 P00352 4/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
VCAM1 P19320 3/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA9 Q16790 2/20 0.33
NMT1 P30419 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CA12 O43570 1/20 0.32
CA3 P07451 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32
CA7 P43166 1/20 0.32
CA13 Q8N1Q1 1/20 0.32
CA14 Q9ULX7 1/20 0.32
CA5B Q9Y2D0 1/20 0.32
GSTO1 P78417 3/20 0.32
TRPV4 Q9HBA0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL642948 0.73 GAA (0.48) ALDH1A1L3MBTL1VCAM1KDM4E
SCHEMBL644589 0.72 GAA (0.47) ALDH1A1L3MBTL1VCAM1KDM4E
SCHEMBL493534 0.72 ACLY (0.36) ACLYALDH1A1L3MBTL1KDM4EGSTO1
SCHEMBL493566 0.71 BDKRB1 (0.42) ALDH1A1L3MBTL1KDM4EGSTO1
SCHEMBL492882 0.71 ALDH1A1 (0.40) ACLYALDH1A1L3MBTL1KDM4E
SCHEMBL645268 0.70 MAPT (0.45) ACLYL3MBTL1VCAM1CA1CA2
SCHEMBL3994728 0.70 ACLY (0.39) ACLYALDH1A1L3MBTL1TRPV4MAPT
SCHEMBL3998000 0.69 ALDH1A1 (0.44) ACLYALDH1A1L3MBTL1KDM4EGSTO1
SCHEMBL13271939 0.68 CA1 (0.41) ALDH1A1CA1CA2CA9TSHR
SCHEMBL1511496 0.67 USP2 (0.39) ACLYALDH1A1L3MBTL1CA2GSTO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD ACLY 80/4885ALDH1A1 1349/4885L3MBTL1 4753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.